Assessment of APOE in atypical parkinsonism syndromes. Neurobiol Dis. 2019.
Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. JAMA Neurol. 2016.
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Nat Med. 2015.
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A. 2013.